These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
901 related articles for article (PubMed ID: 16211221)
1. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221 [TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482 [TBL] [Abstract][Full Text] [Related]
3. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas. Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371 [TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression. Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of cell cycle regulators in gastric carcinoma]. Wu JF; Shao JC; Wang DB; Qin R; Zhang H Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese. Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334 [TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment. Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777 [TBL] [Abstract][Full Text] [Related]
10. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology. Moritani S; Sugihara H; Kushima R; Hattori T Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816 [TBL] [Abstract][Full Text] [Related]
11. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH; Peh SC; Poppema S Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421 [TBL] [Abstract][Full Text] [Related]
12. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606 [TBL] [Abstract][Full Text] [Related]
13. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034 [TBL] [Abstract][Full Text] [Related]
14. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma]. Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332 [TBL] [Abstract][Full Text] [Related]
15. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma. Leung SY; Chau KY; Yuen ST; Chu KM; Branicki FJ; Chung LP Histopathology; 1998 Oct; 33(4):311-7. PubMed ID: 9822919 [TBL] [Abstract][Full Text] [Related]
16. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas. Kim J; Lee HS; Bae SI; Lee YM; Kim WH Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193 [TBL] [Abstract][Full Text] [Related]
17. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas. Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977 [TBL] [Abstract][Full Text] [Related]
19. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594 [TBL] [Abstract][Full Text] [Related]
20. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma. Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S Oncology; 2004; 67(1):81-7. PubMed ID: 15459500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]